Home > News > pSivida and EpiTan Complete First Stage of Proof of Concept Study
May 18th, 2005
pSivida and EpiTan Complete First Stage of Proof of Concept Study
Abstract:
Recent data obtained from the in vivo study conducted at the Institute of Medical and Veterinary Science in Adelaide, South Australia, indicated that a single injection of pSivida's porous BioSilicon(TM) technology successfully released MELANOTAN(TM) over a sustained period.
Source:
businesswire
Bookmark:
Possible Futures
Lifeboat publishes its first book: The Lifeboat Foundation has published its first book, "The Human Race to the Future: What Could Happen -- and What to Do" May 14th, 2013
UC Santa Barbara History Professor's Book Elucidates, Celebrates ‘Visioneers' May 14th, 2013
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
The Global Desalination Market 2013-2023 April 24th, 2013
Nanomedicine
Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013
Protein 'Passport' Helps Nanoparticles Get Past Immune System May 20th, 2013
Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Announcements
JPK reports on single molecule research at IISER Pune in India using AFM and CellHesion techniques May 21st, 2013
Imec and GLOBALFOUNDRIES collaborate to advance high-density memory technology: STT-MRAM offers enhanced performance and scalability for embedded and standalone applications May 21st, 2013
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013